documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
72 rows where docket_id = "FDA-2016-N-0832" sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: subtype, posted_date, posted_month, comment_start_date, comment_end_date, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)
document_type 3
- Supporting & Related Material 38
- Other 30
- Notice 4
agency_id 1
- FDA 72
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2016-N-0832-0072 | FDA | None FDA-2016-N-0832 | Letter to Commissioner Hahn Opposing CVM Proposal | Other | Letter(s) | 2020-07-28T04:00:00Z | 2020 | 7 | 2020-07-28T04:00:00Z | 2020-08-13T17:15:14Z | 0 | 0 | 09000064847aecb6 | ||
| FDA-2016-N-0832-0074 | FDA | None FDA-2016-N-0832 | FDA Memorandum regarding the Separation of Functions for Carbadox | Other | Memorandum | 2020-07-28T04:00:00Z | 2020 | 7 | 2020-07-28T04:00:00Z | 2020-07-28T15:05:04Z | 0 | 0 | 09000064847aecb8 | ||
| FDA-2016-N-0832-0073 | FDA | None FDA-2016-N-0832 | Carbadox Letter July 17 2020 Final (003) | Other | Letter(s) | 2020-07-28T04:00:00Z | 2020 | 7 | 2020-07-28T04:00:00Z | 2020-08-13T17:15:42Z | 0 | 0 | 09000064847aecb7 | ||
| FDA-2016-N-0832-0069 | FDA | None FDA-2016-N-0832 | Phibro Animal Health Corp.; Carbadox in Medicated Swine Feed; Revocation of Approved Method | Notice | Proposed Guidelines | 2020-07-20T04:00:00Z | 2020 | 7 | 2020-07-20T04:00:00Z | 2020-07-21T03:59:59Z | 2020-08-14T15:22:36Z | 2020-15246 | 0 | 0 | 090000648478618d |
| FDA-2016-N-0832-0070 | FDA | None FDA-2016-N-0832 | Phibro Animal Health Corp.; Carbadox in Medicated Swine Feed; Withdrawal of Notice of Opportunity for Hearing | Notice | Withdrawal | 2020-07-20T04:00:00Z | 2020 | 7 | 2020-07-20T04:00:00Z | 2020-07-20T14:42:56Z | 2020-15245 | 0 | 0 | 0900006484786227 | |
| FDA-2016-N-0832-0068 | FDA | None FDA-2016-N-0832 | Letter from FDA CVM to Phibro Animal Health Corporation | Other | Letter(s) | 2020-07-17T04:00:00Z | 2020 | 7 | 2020-07-17T04:00:00Z | 2020-08-13T17:01:02Z | 0 | 0 | 090000648477e2ca | ||
| FDA-2016-N-0832-0067 | FDA | None FDA-2016-N-0832 | Sixth Joint Status Report | Other | Report | 2020-04-30T04:00:00Z | 2020 | 4 | 2020-04-30T04:00:00Z | 2020-04-30T12:50:21Z | 0 | 0 | 0900006484520418 | ||
| FDA-2016-N-0832-0066 | FDA | None FDA-2016-N-0832 | Joint Status Report 5 - FINAL 12-20-19 | Other | Report | 2019-12-20T05:00:00Z | 2019 | 12 | 2019-12-20T05:00:00Z | 2019-12-20T15:18:16Z | 0 | 0 | 0900006484240783 | ||
| FDA-2016-N-0832-0065 | FDA | None FDA-2016-N-0832 | Joint Status Report 4- Final 8-29-19 | Other | Report | 2019-08-29T04:00:00Z | 2019 | 8 | 2019-08-29T04:00:00Z | 2019-08-29T18:28:13Z | 0 | 0 | 0900006483edac12 | ||
| FDA-2016-N-0832-0064 | FDA | None FDA-2016-N-0832 | Third Joint Status Report - Notice of Opportunity for Hearing: Proposal to Withdraw Approval of New Animal Drug Applications for Carbadox in Medicated Swine Feed | Other | Report | 2019-04-30T04:00:00Z | 2019 | 4 | 2019-04-30T04:00:00Z | 2019-04-30T15:02:03Z | 0 | 0 | 0900006483c1df0f | ||
| FDA-2016-N-0832-0063 | FDA | None FDA-2016-N-0832 | Memorandum from Denish M. Hinton to FDA DDM | Other | Memorandum | 2019-03-20T04:00:00Z | 2019 | 3 | 2019-03-20T04:00:00Z | 2019-03-20T14:03:45Z | 0 | 0 | 0900006483b06656 | ||
| FDA-2016-N-0832-0062 | FDA | None FDA-2016-N-0832 | Second Joint Status Report re Carbadox | Other | Report | 2018-12-21T05:00:00Z | 2018 | 12 | 2018-12-21T05:00:00Z | 2018-12-21T15:02:23Z | 0 | 0 | 09000064839bea66 | ||
| FDA-2016-N-0832-0061 | FDA | None FDA-2016-N-0832 | Joint Status Report 1 Final 8-31-18 | Other | Report | 2018-08-31T04:00:00Z | 2018 | 8 | 2018-08-31T04:00:00Z | 2018-08-31T13:28:59Z | 0 | 0 | 090000648368487d | ||
| FDA-2016-N-0832-0060 | FDA | None FDA-2016-N-0832 | Carbadox Letter March 30 18 | Other | Letter(s) | 2018-04-02T04:00:00Z | 2018 | 4 | 2018-04-02T04:00:00Z | 2018-04-02T13:27:35Z | 0 | 0 | 0900006483085912 | ||
| FDA-2016-N-0832-0059 | FDA | None FDA-2016-N-0832 | Letter from Covington to FDA | Other | Letter(s) | 2018-03-30T04:00:00Z | 2018 | 3 | 2018-03-30T04:00:00Z | 2018-03-30T16:34:05Z | 0 | 0 | 090000648307537a | ||
| FDA-2016-N-0832-0058 | FDA | None FDA-2016-N-0832 | Legal and FDA Reference Material: Letter, CVM Request to Director Warren 3-16-18 | Other | Request for Extension | 2018-03-21T04:00:00Z | 2018 | 3 | 2018-04-03T13:45:07Z | 0 | 0 | 090000648302a2a0 | |||
| FDA-2016-N-0832-0057 | FDA | None FDA-2016-N-0832 | Letter from Phibro Animal Health Corporation | Other | Letter(s) | 2017-12-29T05:00:00Z | 2017 | 12 | 2017-12-29T05:00:00Z | 2017-12-29T15:57:53Z | 0 | 0 | 0900006482d83a18 | ||
| FDA-2016-N-0832-0056 | FDA | None FDA-2016-N-0832 | Letter from FDA to Covington & Burling, LLP - Extention letter | Other | Extension of Time | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T05:00:00Z | 2017-12-20T20:00:06Z | 0 | 0 | 0900006482d43d53 | ||
| FDA-2016-N-0832-0055 | FDA | None FDA-2016-N-0832 | Letter from FDA to Phibro Animal Health Corporation | Other | Letter(s) | 2017-10-31T04:00:00Z | 2017 | 10 | 2017-10-31T04:00:00Z | 2017-10-31T13:43:18Z | 0 | 0 | 0900006482c291cc | ||
| FDA-2016-N-0832-0054 | FDA | None FDA-2016-N-0832 | Information Request Letter to Phibro (Covington and Burling)7-12-17 | Other | Request | 2017-07-24T04:00:00Z | 2017 | 7 | 2017-07-24T04:00:00Z | 2017-07-24T14:44:46Z | 0 | 0 | 090000648291374d | ||
| FDA-2016-N-0832-0053 | FDA | None FDA-2016-N-0832 | Carbadox Letter May 1 | Other | Response(s) | 2017-05-02T04:00:00Z | 2017 | 5 | 2017-05-02T04:00:00Z | 2017-05-02T21:04:49Z | 0 | 0 | 090000648258bedb | ||
| FDA-2016-N-0832-0052 | FDA | None FDA-2016-N-0832 | Confidential Letter from Center for Veterinary Medicine Recommendation to the Office of Scientific Integrity | Other | Response(s) | 2017-04-25T04:00:00Z | 2017 | 4 | 2017-04-25T04:00:00Z | 2017-04-25T16:52:07Z | 0 | 0 | 0900006482559998 | ||
| FDA-2016-N-0832-0051 | FDA | None FDA-2016-N-0832 | Letter from FDA to Covington & Burling LLP | Other | Letter(s) | 2017-03-17T04:00:00Z | 2017 | 3 | 2017-03-17T04:00:00Z | 2017-03-17T15:53:52Z | 0 | 0 | 0900006482510858 | ||
| FDA-2016-N-0832-0048 | FDA | None FDA-2016-N-0832 | Letter from Office of the General Counsel to FDA OC and Covington & Burling, LLP (Phibro) | Other | Letter(s) | 2017-03-14T04:00:00Z | 2017 | 3 | 2017-03-14T04:00:00Z | 2017-03-14T20:06:05Z | 0 | 0 | 09000064825077d6 | ||
| FDA-2016-N-0832-0050 | FDA | None FDA-2016-N-0832 | Letter from FDA Office of Scientific Integrity to Covington & Burling, LLP (Phibro) and Office of the Chief Counsel | Other | Letter(s) | 2017-03-14T04:00:00Z | 2017 | 3 | 2017-03-14T04:00:00Z | 2017-03-14T20:29:29Z | 0 | 0 | 09000064825077d8 | ||
| FDA-2016-N-0832-0049 | FDA | None FDA-2016-N-0832 | Follow up emails between FDA and Covington & Burling, LLP (Phibro) | Other | General Correspondence | 2017-03-14T04:00:00Z | 2017 | 3 | 2017-03-14T04:00:00Z | 2017-03-14T20:13:15Z | 0 | 0 | 09000064825077d7 | ||
| FDA-2016-N-0832-0047 | FDA | None FDA-2016-N-0832 | Letter from Covington & Burling LLP (Phibro) to FDA OC | Other | Letter(s) | 2017-03-14T04:00:00Z | 2017 | 3 | 2017-03-14T04:00:00Z | 2017-03-14T20:00:44Z | 0 | 0 | 09000064825077d5 | ||
| FDA-2016-N-0832-0046 | FDA | None FDA-2016-N-0832 | Letter granting CVM's request for an extension | Other | Letter(s) | 2016-11-29T05:00:00Z | 2016 | 11 | 2016-11-29T05:00:00Z | 2016-11-29T15:18:48Z | 0 | 0 | 09000064823c6e21 | ||
| FDA-2016-N-0832-0045 | FDA | None FDA-2016-N-0832 | Letter to Petitioner | Other | Letter(s) | 2016-10-05T04:00:00Z | 2016 | 10 | 2016-10-05T04:00:00Z | 2016-10-05T16:54:57Z | 0 | 0 | 090000648229bd86 | ||
| FDA-2016-N-0832-0040 | FDA | None FDA-2016-N-0832 | Exhibit 2 Expert Opinion of David H. Bechtel, Ph.D., D.A.B.T. re: Request for Hearing from Phibro Animal Health Corporation Redacted CV | Supporting & Related Material | Background Material | 2016-07-15T04:00:00Z | 2016 | 7 | 2016-07-15T15:59:53Z | 0 | 0 | 09000064820b5e32 | |||
| FDA-2016-N-0832-0043 | FDA | None FDA-2016-N-0832 | Exhibit 7 Expert Opinion of Stephen Scypinski, Ph.D. re: Request for Hearing from Phibro Animal Health Corporation Redacted CV | Supporting & Related Material | Background Material | 2016-07-15T04:00:00Z | 2016 | 7 | 2016-07-15T16:00:57Z | 0 | 0 | 09000064820b5e35 | |||
| FDA-2016-N-0832-0042 | FDA | None FDA-2016-N-0832 | Exhibit 4 Expert Opinion of John G. Dorsey, Ph.D. re: Request for Hearing from Phibro Animal Health Corporation Redacted CV | Supporting & Related Material | Background Material | 2016-07-15T04:00:00Z | 2016 | 7 | 2016-07-15T16:00:01Z | 0 | 0 | 09000064820b5e34 | |||
| FDA-2016-N-0832-0041 | FDA | None FDA-2016-N-0832 | Exhibit 3 Expert Opinion of Neil. Kelleher, Ph.D. re: Request for Hearing from Phibro Animal Health Corporation Redacted CV | Supporting & Related Material | Background Material | 2016-07-15T04:00:00Z | 2016 | 7 | 2016-07-15T15:59:56Z | 0 | 0 | 09000064820b5e33 | |||
| FDA-2016-N-0832-0044 | FDA | None FDA-2016-N-0832 | Exhibit 8 Expert Opinion of Robert D. Gibbons, Ph.D. re: Request for Hearing from Phibro Animal Health Corporation Redacted CV | Supporting & Related Material | Background Material | 2016-07-15T04:00:00Z | 2016 | 7 | 2016-07-15T16:01:58Z | 0 | 0 | 09000064820b5e36 | |||
| FDA-2016-N-0832-0038 | FDA | None FDA-2016-N-0832 | Exhibit 20 Corey Grass, C. F. Grass Consulting, Impact & Cost if Mecadox Was Not Available (June 2016) re: Request for Hearing from Phibro Animal Health Corporation | Supporting & Related Material | Background Material | 2016-07-12T04:00:00Z | 2016 | 7 | 2016-07-13T16:58:17Z | 0 | 0 | 09000064820a3173 | |||
| FDA-2016-N-0832-0031 | FDA | None FDA-2016-N-0832 | Exhibit 6 FDA Location Directory (July 1990) re: Request for Hearing from Phibro Animal Health Corporation | Supporting & Related Material | Background Material | 2016-07-12T04:00:00Z | 2016 | 7 | 2016-07-13T16:57:07Z | 0 | 0 | 09000064820a3165 | |||
| FDA-2016-N-0832-0036 | FDA | None FDA-2016-N-0832 | Exhibit 14 M. Karlsson, et al Decreased Susceptibility to Tiamulin in German Isolates of Brachyspira hyodysenteriae (Paper 43), Proc. 17th Int. Pig Vet. Soc. Cong., Ames, Iowa (2002) re: Request for Hearing from Phibro Animal Health Corporation | Supporting & Related Material | Background Material | 2016-07-12T04:00:00Z | 2016 | 7 | 2016-07-13T16:57:57Z | 0 | 0 | 09000064820a316d | |||
| FDA-2016-N-0832-0030 | FDA | None FDA-2016-N-0832 | Exhibit 5 Proceedings of the EuroResidue Conference, Noorwijkerhout re: Request for Hearing from Phibro Animal Health Corporation | Supporting & Related Material | Background Material | 2016-07-12T04:00:00Z | 2016 | 7 | 2016-07-13T16:56:58Z | 0 | 0 | 09000064820a3111 | |||
| FDA-2016-N-0832-0032 | FDA | None FDA-2016-N-0832 | Exhibit 9 Declaration of Paul Duquette re: Request for Hearing from Phibro Animal Health Corporation | Supporting & Related Material | Background Material | 2016-07-12T04:00:00Z | 2016 | 7 | 2016-07-13T16:57:18Z | 0 | 0 | 09000064820a3168 | |||
| FDA-2016-N-0832-0033 | FDA | None FDA-2016-N-0832 | Exhibit 10 Declaration of Kevin Bynum re: Request for Hearing from Phibro Animal Health Corporation | Supporting & Related Material | Background Material | 2016-07-12T04:00:00Z | 2016 | 7 | 2016-07-13T16:57:26Z | 0 | 0 | 09000064820a3169 | |||
| FDA-2016-N-0832-0035 | FDA | None FDA-2016-N-0832 | Exhibit 12 R. Korty, et al A Cost Effective Alternative to Finishing Depopulation for Swine Dysentery, Am. Ass. Swine Vet. re: Request for Hearing from Phibro Animal Health Corporation | Supporting & Related Material | Background Material | 2016-07-12T04:00:00Z | 2016 | 7 | 2016-07-13T16:57:48Z | 0 | 0 | 09000064820a316b | |||
| FDA-2016-N-0832-0037 | FDA | None FDA-2016-N-0832 | Exhibit 15 A.C.J. Gresham, et al Treatment of Swine Dysentery Problems of Antibiotic Resistance and Concurrent Salmonellosis, 143 Vet. Rec. 619 (1998) re: Request for Hearing from Phibro Animal Health Corporation | Supporting & Related Material | Background Material | 2016-07-12T04:00:00Z | 2016 | 7 | 2016-07-13T16:58:07Z | 0 | 0 | 09000064820a316e | |||
| FDA-2016-N-0832-0034 | FDA | None FDA-2016-N-0832 | Exhibit 11 John C.S. Harding, Emergence of"Brachyspira hampsonii" in Western Canada: A Collaborative Success, Am. Ass. Swine Vet. 12-21 (2016) re: Request for Hearing from Phibro Animal Health Corporation | Supporting & Related Material | Background Material | 2016-07-12T04:00:00Z | 2016 | 7 | 2016-07-13T16:57:39Z | 0 | 0 | 09000064820a316a | |||
| FDA-2016-N-0832-0039 | FDA | None FDA-2016-N-0832 | Exhibit 21 Timeline April 2015 to April 2016: Summary of communications between Phibro Animal Health Corporation (PAH) and CVM re: Request for Hearing from Phibro Animal Health Corporation | Supporting & Related Material | Background Material | 2016-07-12T04:00:00Z | 2016 | 7 | 2016-07-13T16:58:26Z | 0 | 0 | 09000064820a3174 | |||
| FDA-2016-N-0832-0029 | FDA | None FDA-2016-N-0832 | Request for Hearing from Phibro Animal Health Corporation | Other | Request for Hearing | 2016-07-12T04:00:00Z | 2016 | 7 | 2016-04-12T04:00:00Z | 2016-07-12T03:59:59Z | 2016-07-13T16:04:37Z | 0 | 0 | 09000064820a1fdb | |
| FDA-2016-N-0832-0027 | FDA | None FDA-2016-N-0832 | Phibro Animal Health Corp.; Carbadox in Medicated Swine Feed; Opportunity for Hearing; Correction | Notice | Meeting | 2016-04-21T04:00:00Z | 2016 | 4 | 2016-04-21T04:00:00Z | 2016-04-21T15:22:46Z | 2016-09265 | 0 | 0 | 0900006481f7cd6a | |
| FDA-2016-N-0832-0026 | FDA | None FDA-2016-N-0832 | Request for Hearing from Phibro Animal Health Corporation | Other | Request for Hearing | 2016-04-19T04:00:00Z | 2016 | 4 | 2016-04-19T04:00:00Z | 2016-04-19T14:38:49Z | 0 | 0 | 0900006481f6c57f | ||
| FDA-2016-N-0832-0025 | FDA | None FDA-2016-N-0832 | Reference List re Phibro Animal Health Corp.; Carbadox in Medicated Swine Feed; Opportunity for Hearing | Supporting & Related Material | Background Material | 2016-04-15T04:00:00Z | 2016 | 4 | 2016-04-15T14:18:36Z | 0 | 0 | 0900006481f6c898 | |||
| FDA-2016-N-0832-0024 | FDA | None FDA-2016-N-0832 | FDA Memorandum regarding the Separation of Functions for Carbadox | Other | Memorandum | 2016-04-13T04:00:00Z | 2016 | 4 | 2016-04-13T04:00:00Z | 2016-04-13T15:08:39Z | 0 | 0 | 0900006481f65aca | ||
| FDA-2016-N-0832-0013 | FDA | None FDA-2016-N-0832 | Reference 12 FDA Memorandum dtd. July 29, 1975 re Phibro Animal Health Corp.; Carbadox in Medicated Swine Feed; Opportunity for Hearing | Supporting & Related Material | Background Material | 2016-04-12T04:00:00Z | 2016 | 4 | 2016-04-15T13:44:51Z | 0 | 0 | 0900006481f56773 | |||
| FDA-2016-N-0832-0019 | FDA | None FDA-2016-N-0832 | Reference 18 Report, 28th Codex Session, Rome, 2005 re Phibro Animal Health Corp.; Carbadox in Medicated Swine Feed; Opportunity for Hearing | Supporting & Related Material | Background Material | 2016-04-12T04:00:00Z | 2016 | 4 | 2016-04-15T13:48:05Z | 0 | 0 | 0900006481f5677e | |||
| FDA-2016-N-0832-0023 | FDA | None FDA-2016-N-0832 | Reference 22 FDA Memorandum dtd. July 29, 2012 re Phibro Animal Health Corp.; Carbadox in Medicated Swine Feed; Opportunity for Hearing | Supporting & Related Material | Background Material | 2016-04-12T04:00:00Z | 2016 | 4 | 2016-04-15T13:50:07Z | 0 | 0 | 0900006481f56782 | |||
| FDA-2016-N-0832-0017 | FDA | None FDA-2016-N-0832 | Reference 16 FOI Summary for sNADA 041-061, approved Oct. 5, 1998 re Phibro Animal Health Corp.; Carbadox in Medicated Swine Feed; Opportunity for Hearing | Supporting & Related Material | Background Material | 2016-04-12T04:00:00Z | 2016 | 4 | 2016-04-15T13:46:54Z | 0 | 0 | 0900006481f56777 | |||
| FDA-2016-N-0832-0004 | FDA | None FDA-2016-N-0832 | Reference 3 FDA Memorandum dtd. Mar. 17, 2014 re Phibro Animal Health Corp.; Carbadox in Medicated Swine Feed; Opportunity for Hearing | Supporting & Related Material | Background Material | 2016-04-12T04:00:00Z | 2016 | 4 | 2016-04-15T13:40:35Z | 0 | 0 | 0900006481f56d1d | |||
| FDA-2016-N-0832-0006 | FDA | None FDA-2016-N-0832 | Reference 5 Baars, A.J., et al., 1990 re Phibro Animal Health Corp.; Carbadox in Medicated Swine Feed; Opportunity for Hearing | Supporting & Related Material | Background Material | 2016-04-12T04:00:00Z | 2016 | 4 | 2016-04-15T13:41:29Z | 0 | 0 | 0900006481f56d1f | |||
| FDA-2016-N-0832-0008 | FDA | None FDA-2016-N-0832 | Reference 7 CVM GFI #3, July 25, 2006 re Phibro Animal Health Corp.; Carbadox in Medicated Swine Feed; Opportunity for Hearing | Supporting & Related Material | Background Material | 2016-04-12T04:00:00Z | 2016 | 4 | 2016-04-15T13:42:23Z | 0 | 0 | 0900006481f5676e | |||
| FDA-2016-N-0832-0009 | FDA | None FDA-2016-N-0832 | Reference 8 FDA Memorandum dtd. Sept. 22, 1972 re Phibro Animal Health Corp.; Carbadox in Medicated Swine Feed; Opportunity for Hearing | Supporting & Related Material | Background Material | 2016-04-12T04:00:00Z | 2016 | 4 | 2016-04-15T13:42:50Z | 0 | 0 | 0900006481f5676f | |||
| FDA-2016-N-0832-0014 | FDA | None FDA-2016-N-0832 | Reference 13 Citizen Petition, FDA Docket No. 86P-0212, May 9, 1986 re Phibro Animal Health Corp.; Carbadox in Medicated Swine Feed; Opportunity for Hearing | Supporting & Related Material | Background Material | 2016-04-12T04:00:00Z | 2016 | 4 | 2016-04-15T13:45:23Z | 0 | 0 | 0900006481f56774 | |||
| FDA-2016-N-0832-0010 | FDA | None FDA-2016-N-0832 | Reference 9 FDA Memorandum dtd. Aug. 27, 1970 re Phibro Animal Health Corp.; Carbadox in Medicated Swine Feed; Opportunity for Hearing | Supporting & Related Material | Background Material | 2016-04-12T04:00:00Z | 2016 | 4 | 2016-04-15T13:43:25Z | 0 | 0 | 0900006481f56770 | |||
| FDA-2016-N-0832-0012 | FDA | None FDA-2016-N-0832 | Reference 11 FDA Memorandum dtd. July 7, 1972 re Phibro Animal Health Corp.; Carbadox in Medicated Swine Feed; Opportunity for Hearing | Supporting & Related Material | Background Material | 2016-04-12T04:00:00Z | 2016 | 4 | 2016-04-15T13:44:24Z | 0 | 0 | 0900006481f56772 | |||
| FDA-2016-N-0832-0002 | FDA | None FDA-2016-N-0832 | Reference 1 FOI Summary for sNADA 041-061, approved Jan. 30, 1998 re Phibro Animal Health Corp.; Carbadox in Medicated Swine Feed; Opportunity for Hearing | Supporting & Related Material | Background Material | 2016-04-12T04:00:00Z | 2016 | 4 | 2016-04-15T13:39:41Z | 0 | 0 | 0900006481f56d1b | |||
| FDA-2016-N-0832-0022 | FDA | None FDA-2016-N-0832 | Reference 21 CVM GFI #208 - VICH GL49, Sept. 15, 2011 re Phibro Animal Health Corp.; Carbadox in Medicated Swine Feed; Opportunity for Hearing | Supporting & Related Material | Background Material | 2016-04-12T04:00:00Z | 2016 | 4 | 2016-04-15T13:49:39Z | 0 | 0 | 0900006481f56781 | |||
| FDA-2016-N-0832-0015 | FDA | None FDA-2016-N-0832 | Reference 14 Response to Citizen Petition, FDA Docket No. 86P-0212, May 30, 1995 re Phibro Animal Health Corp.; Carbadox in Medicated Swine Feed; Opportunity for Hearing | Supporting & Related Material | Background Material | 2016-04-12T04:00:00Z | 2016 | 4 | 2016-04-15T13:45:52Z | 0 | 0 | 0900006481f56775 | |||
| FDA-2016-N-0832-0018 | FDA | None FDA-2016-N-0832 | Reference 17 FOI Summary for oNADA 141-211, approved July 21, 2004 re Phibro Animal Health Corp.; Carbadox in Medicated Swine Feed; Opportunity for Hearing | Supporting & Related Material | Background Material | 2016-04-12T04:00:00Z | 2016 | 4 | 2016-04-15T13:47:23Z | 0 | 0 | 0900006481f5677d | |||
| FDA-2016-N-0832-0007 | FDA | None FDA-2016-N-0832 | Reference 6 Baars, A.J., et al., 1991 Residues of Carbadox Metabolites in Edible Pork Products re Phibro Animal Health Corp.; Carbadox in Medicated Swine Feed; Opportunity for Hearing | Supporting & Related Material | Background Material | 2016-04-12T04:00:00Z | 2016 | 4 | 2016-04-15T13:41:56Z | 0 | 0 | 0900006481f56d20 | |||
| FDA-2016-N-0832-0011 | FDA | None FDA-2016-N-0832 | Reference 10 1990 JECFA report carbadox re Phibro Animal Health Corp.; Carbadox in Medicated Swine Feed; Opportunity for Hearing | Supporting & Related Material | Background Material | 2016-04-12T04:00:00Z | 2016 | 4 | 2016-04-15T13:43:56Z | 0 | 0 | 0900006481f56771 | |||
| FDA-2016-N-0832-0001 | FDA | None FDA-2016-N-0832 | Phibro Animal Health Corp.; Carbadox in Medicated Swine Feed; Opportunity for Hearing | Notice | Notice of Opportunity of Hearing | 2016-04-12T04:00:00Z | 2016 | 4 | 2016-04-12T04:00:00Z | 2016-07-12T03:59:59Z | 2020-08-14T15:22:11Z | 2016-08327 | 0 | 0 | 0900006481f61268 |
| FDA-2016-N-0832-0016 | FDA | None FDA-2016-N-0832 | Reference 15 FDA Memorandum dtd. Sept. 7, 1994 re Phibro Animal Health Corp.; Carbadox in Medicated Swine Feed; Opportunity for Hearing | Supporting & Related Material | Background Material | 2016-04-12T04:00:00Z | 2016 | 4 | 2016-04-15T13:46:25Z | 0 | 0 | 0900006481f56776 | |||
| FDA-2016-N-0832-0021 | FDA | None FDA-2016-N-0832 | Reference 20 Macintosh, A.I., et al., 1985 re Phibro Animal Health Corp.; Carbadox in Medicated Swine Feed; Opportunity for Hearing | Supporting & Related Material | Background Material | 2016-04-12T04:00:00Z | 2016 | 4 | 2016-04-15T13:49:11Z | 0 | 0 | 0900006481f56780 | |||
| FDA-2016-N-0832-0005 | FDA | None FDA-2016-N-0832 | Reference 4 Boison, J.O., et al., 2009 re Phibro Animal Health Corp.; Carbadox in Medicated Swine Feed; Opportunity for Hearing | Supporting & Related Material | Background Material | 2016-04-12T04:00:00Z | 2016 | 4 | 2016-04-15T13:41:01Z | 0 | 0 | 0900006481f56d1e | |||
| FDA-2016-N-0832-0020 | FDA | None FDA-2016-N-0832 | Reference 19 CVM GFI #205 VICH GL46, Sept. 15, 2011 re Phibro Animal Health Corp.; Carbadox in Medicated Swine Feed; Opportunity for Hearing | Supporting & Related Material | Background Material | 2016-04-12T04:00:00Z | 2016 | 4 | 2016-04-15T13:48:34Z | 0 | 0 | 0900006481f5677f | |||
| FDA-2016-N-0832-0003 | FDA | None FDA-2016-N-0832 | Reference 2 2003 JECFA report on carbadox re Phibro Animal Health Corp.; Carbadox in Medicated Swine Feed; Opportunity for Hearing | Supporting & Related Material | Background Material | 2016-04-12T04:00:00Z | 2016 | 4 | 2016-04-15T13:40:07Z | 0 | 0 | 0900006481f56d1c |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;